Passive transfer studies in demyelinating neuropathy with IgM monoclonal antibodies to myelin-associated glycoprotein.

AUTOR(ES)

Steck, A J

RESUMO

Serum or IgM fraction from two patients with a demyelinating neuropathy and IgM monoclonal antibodies to myelin-associated glycoprotein were injected in three different animal species. There were no clinical, electrophysiological or morphological signs of demyelination in either chronic or acute passive transfer experiments. These results suggest that the pathogenesis of this human demyelinating neuropathy may be more complex than has been assumed.

Documentos Relacionados

• IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside.
• Gangliosides are neuronal ligands for myelin-associated glycoprotein.
• Molecular cloning and primary structure of myelin-associated glycoprotein.
• Murine monoclonal antibodies to the myelin-associated glycoprotein react with large granular lymphocytes of human blood.
• Phylogenetically conserved antigen on nerve cells and lymphocytes resembles myelin-associated glycoprotein.